1. Home
  2. VRRM vs APLS Comparison

VRRM vs APLS Comparison

Compare VRRM & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRRM
  • APLS
  • Stock Information
  • Founded
  • VRRM 1987
  • APLS 2009
  • Country
  • VRRM United States
  • APLS United States
  • Employees
  • VRRM N/A
  • APLS N/A
  • Industry
  • VRRM Transportation Services
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • VRRM Consumer Discretionary
  • APLS Health Care
  • Exchange
  • VRRM Nasdaq
  • APLS Nasdaq
  • Market Cap
  • VRRM 3.9B
  • APLS 3.5B
  • IPO Year
  • VRRM N/A
  • APLS 2017
  • Fundamental
  • Price
  • VRRM $23.77
  • APLS $23.80
  • Analyst Decision
  • VRRM Strong Buy
  • APLS Buy
  • Analyst Count
  • VRRM 4
  • APLS 20
  • Target Price
  • VRRM $27.88
  • APLS $33.47
  • AVG Volume (30 Days)
  • VRRM 991.7K
  • APLS 2.3M
  • Earning Date
  • VRRM 10-30-2025
  • APLS 11-04-2025
  • Dividend Yield
  • VRRM N/A
  • APLS N/A
  • EPS Growth
  • VRRM N/A
  • APLS N/A
  • EPS
  • VRRM 0.24
  • APLS N/A
  • Revenue
  • VRRM $906,330,000.00
  • APLS $754,649,000.00
  • Revenue This Year
  • VRRM $8.04
  • APLS $22.11
  • Revenue Next Year
  • VRRM $7.48
  • APLS N/A
  • P/E Ratio
  • VRRM $100.22
  • APLS N/A
  • Revenue Growth
  • VRRM 6.24
  • APLS 20.02
  • 52 Week Low
  • VRRM $19.51
  • APLS $16.10
  • 52 Week High
  • VRRM $27.83
  • APLS $35.72
  • Technical
  • Relative Strength Index (RSI)
  • VRRM 39.48
  • APLS 47.98
  • Support Level
  • VRRM $23.56
  • APLS $21.07
  • Resistance Level
  • VRRM $25.11
  • APLS $23.50
  • Average True Range (ATR)
  • VRRM 0.60
  • APLS 0.80
  • MACD
  • VRRM -0.05
  • APLS -0.03
  • Stochastic Oscillator
  • VRRM 13.55
  • APLS 78.45

About VRRM Verra Mobility Corporation

Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: